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Genetic loci for bodymass index (BMI) inadolescence and young adulthood, aperiod of high risk for weight gain,
are understudied, yet may yield important insight into the etiology of obesity and early intervention. To identify
novel genetic loci and examine the influence of known loci on BMI during this critical time period in late adoles-
cence and early adulthood, we performed a two-stage meta-analysis using 14 genome-wide association studies
in populations of European ancestry with data on BMI between ages 16 and 25 in up to 29 880 individuals. We
identified seven independent loci (P < 5.0 3 1028) near FTO (P 5 3.72 3 10223), TMEM18 (P 5 3.24 3 10217),
MC4R (P 5 4.41 3 10217), TNNI3K (P 5 4.32 3 10211), SEC16B (P 5 6.24 3 1029), GNPDA2 (P 5 1.11 3 1028)
and POMC (P 5 4.94 3 1028) as well as a potential secondary signal at the POMC locus (rs2118404, P 5 2.4 3
1025 after conditioning on the established single-nucleotide polymorphism at this locus) in adolescents and
young adults. To evaluate the impact of the established genetic loci on BMI at these young ages, we examined
differences between the effect sizes of 32 published BMI loci in European adult populations (aged 18–90) and
those observed in our adolescent and young adult meta-analysis. Four loci (near PRKD1, TNNI3K, SEC16B
and CADM2) had larger effects and one locus (near SH2B1) had a smaller effect on BMI during adolescence
and young adulthood compared with older adults (P < 0.05). These results suggest that genetic loci for BMI
can vary in their effects across the life course, underlying the importance of evaluating BMI at different ages.
INTRODUCTION
The period of adolescence and young adulthood is recognized as
a period of elevated risk for excess weight gain (1–3). In the past
5 years, genome-wide association studies (GWASs) have identi-
fied over 30 common genetic loci associated with body mass
index (BMI, kg/m2) mainly in European adult samples, with an
average age often greater than 50 (4–10). Whereas several loci
identified in adults have also been found to be associated with
BMI in childhood (6,11–20) and two loci were recently identi-
fied in childhood obesity (17), little is known about these
obesity susceptibility loci across high-risk periods for weight
gain, such as adolescence and young adulthood. The influence
of these loci in adolescence and young adulthood remains
largely speculative from previously established association
studies that illustrate the association of these loci on BMI
during middle-aged adulthood and/or childhood.
The purpose of the current study was to conduct a two-stage
GWAS for genetic loci influencing BMI during late adolescence
and early adulthood (aged 16–25). Furthermore, we sought to
compare estimates of effect sizes on BMI for the 32 BMI loci pre-
viously identified in European middle-aged adults (4) to effect
sizesobserved inadolescentandyoungadultsofEuropeandescent.
RESULTS
In the discovery meta-analysis of 10 GWASs, we observed an
excess of small P-values compared with chance alone, an
excess that was somewhat diminished when the known BMI
loci were removed (Supplementary Material, Fig. S1a, Q–Q
plot). Although our initial analyses were stratified by gender,
Q–Q plots of the observed versus expected P-values for hetero-
geneity between men and women suggested similar results by
gender; thus, all results are presented for the combined sample.
A total of four independent loci (as defined as separated by at
least 1 Mb), rs9940128 (near FTO), rs12463617 (near
TMEM18), rs7234864 (near MC4R) and rs12142020 (near
TNNI3K), reached genome-wide significance (P , 5.0 ×
1028) in the discovery sample (Supplementary Material,
Fig. S1b), and after filtering the results for the single-nucleotide
polymorphisms (SNPs) using a distance criteria of+500 kb and
linkage disequilibrium threshold of r2, 0.1, the top 76 SNPs
with P , 5 × 1025 were taken forward for follow-up in four
studies. From the combined meta-analysis of the discovery and
follow-up results, seven independent loci (P , 5.0 × 1028;
Table 1 and Supplementary Material, Fig. S2) near FTO
(rs9940128, P ¼ 3.72 × 10223), TMEM18 (rs12463617,
P ¼ 3.24 × 10217), MC4R/PMAIP1 (rs7234864, P ¼ 4.41 ×
10217), TNNI3K (rs12142020, P ¼ 4.32 × 10211), SEC16B
(rs591120, P ¼ 6.24 × 1029), GNPDA2 (rs13130484, P ¼
1.11 × 1028) and POMC (rs1561288, P ¼ 4.94 × 1028)
reached genome-wide statistical significance. There was little
heterogeneitybetween the studies forall sevenSNPs (Supplemen-
tary Material, Fig. S3a–g, Pheterogeneity ≥ 0.06). All seven SNPs
fell within 1 Mb of previously established loci, and five of the
seven were highly correlated (r2. 0.7) with the reported SNP
from the Genetic Investigation of ANThropometric Traits
(GIANT) consortium (4). Two of the seven SNPs (rs591120
near SEC16B and rs1561288 near POMC) and a second possible
signal near MC4R (rs17066846) were only weakly correlated
(r2≤ 0.3) with the previously published loci (4). We performed
conditional analyses within a 1 Mb region on either side of
these three SNPs to identify additional independent SNPs.
Results for meta-analysis of region 1 (chromosome 1,
175.8–176.8 Mb, captures SEC16B) conditioned on our most
3598 Human Molecular Genetics, 2013, Vol. 22, No. 17
significant SNP, rs591120, in the adolescent/young adult sample
or the GIANT SNP rs543874 suggest that the identified SEC16B
SNPs are not independent (Table 2 and Supplementary Material,
Fig. S4a and c). Meta-analysis of region 3 (chromosome 18,
55.5–56.6 Mb, captures MC4R and PMAIP1) conditioned on
the GIANT SNP rs571312 indicated that rs17066846 is simply
another marker tagging this locus (P ¼ 0.5 after conditioning
on rs571312) and that SNPs in that region are also not independ-
ent (Table 2 and Supplementary Material, Fig. S4b and d). In
contrast, meta-analysis of region 2 (chromosome 2, 24.8–
25.8 Mb, captures ADCY3, POMC and DTNB) conditioned
either on rs1561288, the most significant SNP identified in the
primary adolescent/young adult meta-analysis, or on the
GIANT SNP rs713586 suggests that rs1561288 is a possible
second locus in the chromosome 2 region (Table 2 and Fig. 1A
and B). Because the studies used for the unconditional and con-
ditional analysis comparison were slightly different than for the
primary meta-analysis, we also show conditional results for
rs2118404, which was the most significant SNP in this region
before conditioning and remained the most significant SNP
after conditioning in this sample. Rs2118404 is highly correlated
with rs1561288 (r2 ¼ 1.0), and thus, these two SNPs represent
the same signal.
We evaluated the 32 loci that had been previously published
for BMI in middle-aged European adults from the GIANT con-
sortium (4). Of the 32 published SNPs representing these loci, we
observed consistent direction of effects with BMI in the adoles-
cent/young adult meta-analysis for all SNPs except one, SH2B1
(Table 3), and nominal statistical significance (P , 0.05) was
achieved for 27 SNPs. A comparison of the published effect
sizes for BMI in middle-aged adults (GIANT) and the observed
effect sizes in our adolescent/young adult meta-analysis for these
32 SNPs showed that at P, 0.05, four SNPs, rs11847697 (near
PRKD1), rs1514175 (near TNNI3K), rs543874 (near SEC16B)
and rs13078807 (near CADM2), had larger effect estimates in
the adolescent/young adult meta-analysis and rs7359397 (near
SH2B1) had a smaller estimate compared with the GIANT ana-
lysis based on middle-aged adults. Even though we had greater
than 85% power to detect the previously published effect sizes
(4), we failed to find a nominally significant effect on BMI for
rs7359397 (near SH2B1) as well as for rs10150332 (near
NRXN3), rs10968576 (near LRRN6NC) and rs2287019 (near
QPCTL). We also failed to detect a nominally significant
effect for rs887912 (near FANCL), but this could have been
because we lacked sufficient power.
A genome-wide comparison of the differences in effect sizes
between middle-aged adults (GIANT) and adolescent/young
adults did not identify any SNPs with differences in effect size
that were genome-wide significant (P, 5 × 1028). After filter-
ing the results based on r2, 0.1 and a distance of+500 kb, we
identified 23 SNPs with differences between effect sizes in
young adult and middle-aged adults at P, 5 × 1025 (Supple-
mentary Material, Table S7). Only one of the 23 SNPs,
rs8055138 (near SH2B1, r2 ¼ 1.0 with the identified GIANT
SNP rs7359397) had an effect size of greater magnitude in
middle-aged adults compared with young adults. The other 22
SNPs had greater effect size in adolescents and young adults
compared with middle-aged adults from GIANT. Among these
22 SNPs was rs2118404 (near POMC), which was identified
from conditional analyses as described above. The other 21T
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SNPs have not been previously reported in the literature for BMI
or obesity.
We also evaluated the 13 SNPs representing 12 loci previously
identified in the literature for obesity in children (Supplementary
Material, Table S6) (9–11,13,17,20,21). For these 13 SNPs, we
observed 10 SNPs with consistent directions of effect with BMI
and five SNPs that displayed Bonferroni corrected (assuming
13 tests) significant associations (P , 0.0038), including the
recently identified SNP near HOX5 (rs9299) (17). The SNP
near OLFM4 (rs9568856) (17) also displayed a nominally sig-
nificant effect in our young adult sample.
Using data from the British 1958 Birth Cohort with BMI at 16
years and the Atherosclerosis Risk in Communities (ARIC)
cohort with BMI at 25 years, we evaluated the proportion of
variance explained by the seven loci identified in our study for
adolescents/young adults as well as the 32 previously identified
loci for BMI from GIANT. The proportion of BMI variance
explained by the two cohorts combined was 1.23% for the 7
loci that reached genome-wide significance in the adolescent/
young adult meta-analysis and 2.89% for the 32 BMI-associated
loci found in GIANT (Supplementary Material, Fig. S5). Within
ARIC, the proportion of variance explained by the seven loci that
reached genome-wide significance in the adolescent/young
adult meta-analysis was 1.17% in young adulthood (i.e. 25
years of age) compared with 0.72% in middle-age adulthood
(i.e. 45–64 years of age). Similarly, the proportion of variance
explained by the 32 established BMI-associated loci was
2.71% for BMI in young adulthood compared with 2.08% for
BMI in middle-aged adulthood in ARIC. To evaluate the
contribution of all common SNPs to the heritability of BMI at
both life stages, we utilized the method proposed by Yang
et al. (22) and implemented in the Genome-wide Complex
Trait Analysis (GCTA) software. In ARIC, we found that the
proportion of genetic variance explained for BMI based on all
common SNPs was 20% in both young adulthood and
middle-aged adulthood.
DISCUSSION
Although GWASs have identified over 40 common genetic loci
associated with BMI in European adult (4–6,9,10,12,13) and
Table 2. Association results for BMI in young adults and adolescents for three separate 1 Mb regions conditioned on the BMI SNP identified by the GIANTa con-
sortium
Gene (Chr: region) SNP(s) of interest
(effect/other allele)
FEA Unconditioned results GIANT locus
conditioned ona
D‘ (R2) Conditioned results
Beta (SE)b P-value Beta (SE)b P-value
SEC16B (Chr1: 175.8–176.8) rs591120 (C/G) 0.44 0.18 (0.03) 6.8E208 rs543874 1.0 (0.31) 0.03 (0.03) 0.3
rs12728890 (T/G) 0.06 0.28 (0.07) 8.3E205 0.13 (0.005) 0.21 (0.07) 2.8E203
POMC (Chr2: 24.8–25.8) rs1561288 (C/T) 0.22 0.22 (0.04) 4.0E208 rs713586 0.92 (0.24) 0.15 (0.04) 2.3E204
crs2118404 (C/T) 0.23 0.26 (0.04) 2.0E209 0.85 (0.21) 0.18 (0.04) 2.4E205
MC4R (Chr 18: 55.5–56.6MB) rs7234864 (T/C) 0.26 0.32 (0.04) 2.0E217 rs571312 0.87 (0.73) 0.05 (0.04) 0.2
rs17066846 (G/T) 0.8 0.20 (0.04) 5.9E206 0.37 (0.11) 0.03 (0.04) 0.5
rs11873305 (A/C) 0.96 0.36 (0.09) 4.6E205 0.12 (0.001) 0.29 (0.09) 4.90E204
BMI, body mass index; FEA, frequency of effect allele (i.e. BMI increasing allele); SE, standard error.
aSEC16B, rs543874; POMC, rs713586; MC4R, rs571312 (published in Speliotes et al.4).
bBMI (kg/m2) per effect allele.
cBecause the studies used for the unconditioned versus conditioned analyses were slightly different than for the primary meta-analysis, we also show rs2118404 that
was the most significant SNP in this region before conditioning and remained the most significant SNP after conditioning in this subset. This SNP is in high LD with
rs1561288 (R2 ¼ 1) and thus essentially the same signal.
Figure1.Potential secondarysignal at POMC contributing to BMI in young adults and adolescents. (A) Plot with unconditioned results illustrating the most significant
SNPs (rs2118404 and rs1561288) and the previously reported SNP (rs713586) in the unconditional analysis. Rs1561288 was the most significant SNP in this region in
the primary analysis, but in the subset of studies used for the conditional analysis, rs2118404 (which has r2 ¼ 1 with rs1561288) was the most significant SNP. (B) Plot
highlighting relevant SNPs after conditioning on previous reported locus, rs713586.
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Table 3. Comparison of association results for the 32 loci associated with BMI in European adults in the GIANT consortiuma with the association results for these SNPs in adolescent/young adults
SNP Nearest
geneb
BMI
increasing
allele
Other
allele
FEAc Results for young adults (discovery and replication) Results for adults (stage 2, reported by GIANT) Difference in effect size, per alleleh
Beta (SE) for
inverse normal
BMI units per
allele
Estimated
effect size for
BMI (kg/m2)
per alleled
n P-value I2 Phet
e Power
(%)f
Beta (SE) for
inverse normal
BIV1I units per
allele
Estimated
effect size for
BMI (kg/m2)
per alleleg
n P-value Beta (SE) for
difference per allele
using inverse
normal BMI units
P-value for
effect
difference
Estimated
effecti size
difference per
allele using
BMI (kg/m2)
rs11847697 PRKD1 T C 0.04 0.101 (0.024) 0.40 28 414 8.43E206 28.5 0.11 51.0 0.041 (0.011) 0.17 85 213 2.25 × 1024 0.06 (0.026) 2.18E202 0.24
rsl514175 TNNI3K A G 0.43 0.060 (0.009) 0.24 29 040 3.40E211 8.8 0.33 55.1 0.019 (0.004) 0.07 118 952 7.04 × 1026 0.041 (0.01) 2.79 E205 0.16
rs543874 SEC16B G A 0.19 0.081 (0.011) 0.32 28 762 4.11E211 35.1 0.05 99.9 0.051 (0.007) 0.22 55 551 2.41 × 10211 0.03 (0.013) 0.026 0.12
rsl3078807 CADM2 G A 0.2 0.049 (0.011) 0.20 28 918 2.86E205 21.2 0.17 67.2 0.021 (0.005) 0.10 113 596 5.32 × 1025 0.028 (0.012) 2.35E202 0.11
rs571312 MC4R A C 0.23 0.078 (0.010) 0.31 29 044 8.69E216 0 0.66 99.9 0.057 (0.006) 0.23 79 788 3.19 × 10221 0.022 (0.012) 0.064 0.09
rsl3107325 SLC39A8 T C 0.07 0.067 (0.018) 0.27 28 555 4.34E205 0 0.87 82.6 0.047 (0.009) 0.19 104 065 1.93 × 1027 0.02 (0.012) 0.10 0.08
rs206936 NUDT3 G A 0.2 0.036 (0.011) 0.14 28 865 7.75E203 0 0.67 30.3 0.016 (0.004) 0.06 125 912 7.39 × 1024 0.02 (0.02) 0.298 0.08
rs4836133 ZNF608 A C 0.48 0.034 (0.009) 0.14 24 804 3.31E204 25 0.14 49.5 0.015 (0.004) 0.07 119 157 1.88 × 1024 0.019 (0.01) 0.057 0.08
rs4771122 MTIF3 G A 0.24 0.038 (0.011) 0.15 28 911 1.36E204 0 0.84 63.7 0.020 (0.006) 0.09 118 733 8.24 × 1024 0.018 (0.01) 0.08 0.07
rs3817334 MTCH2 T C 0.41 0.036 (0.009) 0.14 28 951 9.23E205 1.7 0.44 42.7 0.018 (0.005) 0.06 68 128 1.10 × 1023 0.018 (0.012) 0.136 0.07
rs2112347 FU35779 T G 0.63 0.039 (0.009) 0.16 28 953 5.00E205 4 0.41 82.8 0.022 (0.004) 0.10 93 055 8.29 × 1027 0.017 (0.01) 0.092 0.07
rs2867125 TMEM18 C T 0.83 0.095 (0.011) 0.38 28 954 2.74E216 8.5 0.34 99.9 0.078 (0.006) 0.31 73 973 4.42 × 10230 0.017 (0.013) 0.208 0.07
rs12444979 GPRC5B C T 0.87 0.053 (0.013) 0.21 28 797 1.36E205 2.7 0.42 92.9 0.041 (0.006) 0.17 107 030 8.13 × 10212 0.012 (0.014) 0.39 0.05
rs3810291 TMEM160 A G 0.67 0.033 (0.010) 0.13 28 811 2.59E204 18.8 0.20 71.9 0.021 (0.004) 0.09 122 030 1.59 × 1026 0.011 (0.011) 0.33 0.05
rs713586 RBJ
POMC
C T 0.47 0.046 (0.009) 0.18 28 951 9.35E208 32.8 0.06 98.8 0.035 (0.004) 0.14 115 850 1.44 × 10216 0.01 (0.01) 0.29 0.04
rs2815752 NEGR1 A G 0.61 0.041 (0.009) 0.16 29 050 1.36E205 13.1 0.28 96.9 0.032 (0.005) 0.13 74 531 2.29 × 1029 0.01 (0.01) 0.34 0.04
rs29941 KCTD15 G A 0.67 0.021 (0.009) 0.08 29 049 6.28E203 0 0.73 39.8 0.012 (0.005) 0.05 69 030 2.40 × 1022 0.009 (0.011) 0.43 0.04
rs1555543 PTBP2 C A 0.58 0.024 (0.009) 0.10 28 949 2.94E203 0.5 0.45 42.9 0.017 (0.004) 0.06 74 716 4.48 × 1025 0.007 (0.01) 0.45 0.03
rs987237 TFAP2B G A 0.18 0.038 (0.011) 0.15 28 964 1.70E204 7.5 0.36 85.2 0.032 (0.006) 0.13 71 916 2.40 × 1026 0.006 (0.013) 0.62 0.03
rs2241423 MAP2K5 G A 0.77 0.038 (0.010) 0.15 29 011 1.68E204 0 0.84 90.9 0.032 (0.005) 0.13 104 115 1.59 × 1029 0.006 (0.012) 0.61 0.02
rs9816226 ETV5 T A 0.82 0.038 (0.012) 0.15 28 866 1.75E203 0 0.99 89.8 0.033 (0.006) 0.14 72 362 1.15 × 1026 0.005 (0.013) 0.69 0.02
rsl0938397 GNPDA2 G A 0.43 0.046 (0.009) 0.18 28 951 B.42E208 0 0.59 99.9 0.043 (0.005) 0.18 73 160 1.45 × 10215 0.003 (0.01) 0.76 0.01
rs4929949 RPL27A C T 0.52 0.014 (0.009) 0.06 28 951 0.02 0 0.63 43.8 0.013 (0.004) 0.06 125 931 1.00 × 1023 0.002 (0.01) 0.87 0.01
rs7138803 FAIM2 A G 0.38 0.029 (0.009) 0.12 29 046 1.66E204 0 0.66 93.9 0.028 (0.005) 0.12 76 265 7.82 × 1028 0.001 (0.01) 0.90 0.01
rs887912 FANCL T C 0.29 0.023 (0.009) 0.09 28 911 0.14 32.1 0.06 77.9 0.024 (0.004) 0.10 113 981 1.72 × 1027 0 (0.011) 0.98 0.00
rs2890652 LRP1B C T 0.17 0.023 (0.012) 0.09 28 866 0.03 20.6 0.18 52.8 0.024 (0.006) 0.09 121 816 9.47 × 1025 0 (0.013) 0.98 0.00
rs2287019 QPCTL C T 0.8 0.034 (0.014) 0.14 27 781 0.20 32.2 0.07 94.4 0.037 (0.005) 0.15 94 091 1.40 × 10210 20.003 (0.015) 0.86 20.01
rs1558902 FTO A T 0.42 0.084 (0.009) 0.34 28 249 1.69E222 2.4 0.43 99.9 0.091 (0.005) 0.39 68 498 1.01 × 10260 20.007 (0.01) 0.50 20.03
rsl0150332 NRXN3 C T 0.21 0.020 (0.011) 0.08 28 864 0.06 8 0.35 88.9 0.029 (0.007) 0.13 59 157 2.86 × 1025 20.009 (0.013) 0.50 20.04
rsl0968576 LRRN6C G A 0.31 0.010 (0.009) 0.04 29 052 0.20 14.4 0.25 86.6 0.023 (0.004) 0.11 107 866 3.19 × 1026 20.013 (0.011) 0.23 20.05
rs10767664 BDNF A T 0.78 0.027 (0.011) 0.11 28 865 0.01 0 0.48 99.7 0.047 (0.006) 0.19 80 293 1.17 × 10214 20.021 (0.012) 0.089 20.08
rs7359397 SH2B1 T C 0.61 20.002 (0.009) 20.01 28 947 0.74 9 0.33 99.3 0.034 (0.005) 0.15 80 445 7.89 × 10212 20.037 (0.01) 3.15E204 20.15
Loci are shown from largest to smallest difference in effect size. BMI, body mass index; FEA, frequency of effect allele (i.e. BMI increasing allele); SE, standard error.
aPublished in Speliotes et al.4
bNearest gene within 500 kb of the indicated SNP.
cFrequency of the effect allele, similar in GIANT adult cohorts.
dCalculated from effect size of stage 1 and 2 results and SD of BMI in all cohorts (SD ¼ 4.0 kg/m2).
eHeterogeneity quantified the effect of inconsistency across the studies (all results files) and was calculated using CochraneQ and comparing in two ways: (i) with the x2 distribution with k2 1 degrees of freedom, where k ¼ 27 input results
files (Phet ¼ P-value using x2); and (ii) with the I2, the percentage of total variation across studies that is due to heterogeneity, that is calculated as I2 ¼ 100% 3 (Q 2 df)/Q, where Q is the Cochrane Q and df the degrees of freedom.
fPower estimated using QUANTO. Power estimates per locus included allele frequencies (FEA), sample size and mean BMI (mean+SD) ¼ 23.0 kg/m2+ 4.0 from young adult data in current study, and effect estimates from those reported
for adults in the GIANT study. The type 1 error rate set at a ¼ 0.05, to detect nominally significant effect estimates.
gReported effects from stage 2 cohorts only; calculated using effect size × SD of mean BMI.
hFour larger effect sizes [+Beta (SE) for difference andP , 0.05] in young adults and one smaller effect size in young adults [2Beta (SE) for difference andP, 0.05] compared with GIANT stage 2 results in adults. Beta difference calculated
using z-statistic including Goncalo’s correction for correlated data with Pearson r ¼ 0.08: (Beta_A 2 Beta_B)/SQRT[(SE_A)2 + (SE_B)2] 2 2 × 0.08 × SE_A × SE_B, where Beta_A and SE_A are from the young adult sample and
Beta_B and SE_B are from the GIANT stage 2 sample.
iCalculated using effect size × SD of mean BMI.
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pediatric (6,9,10,13,15–20) studies, the extent to which these
findings can be generalized to other life-cycle periods is an
open question. In our analysis of 16–25-year olds of European
descent, a life-cycle period of elevated risk for weight gain, we
found seven genome-wide significant loci (FTO, TMEM18,
MC4R, TNNI3K, SEC16B, GNDPA2 and POMC) associated
with BMI. All seven loci were previously identified in European
adult populations (4). Furthermore, all have been identified as
being associated with obesity in children (6,15,17). Interesting-
ly, although SNP rs1561288 showed partial dependence on the
previously identified index SNP in the region, we found suggest-
ive evidence for a secondary signal in the POMC region from the
conditional analyses. Except for SH2B1, the other BMI loci
identified in European adults displayed directionally consistent
effect estimates during the adolescent/young adult period.
Further, 27 of 32 loci were nominally significant (P, 0.05).
For the 13 loci identified for obesity in children, 10 showed
consistent direction of effect and 6 were nominally significant
(P, 0.05). Taken together, our results support the generaliza-
tion of at least most of the genetic obesity loci across the lifespan.
Differences in the effect sizes for the 32 known BMI loci in
adults (average age 55 years) relative to the adolescents and
young adults were statistically significant (at P , 0.05) for
five loci. For four loci (PRKD1, TNNI3K, SEC16B and
CADM2), the effect sizes were larger in adolescence/young
adulthood compared with middle-age adulthood, but for the
locus near SH2B1 (rs7359397), the effect size was larger in
later adulthood. Even after correction for multiple testing,
rs1514715 (near TNNI3K) and rs7359397 (near SH2B1)
remained significantly different. Although the differences in
size for the other 27 loci were not nominally significant, absolute
differences in effect estimates showed that 20 of 27 SNPs
had larger effect sizes in adolescent/young adults compared
with middle-aged adults (Table 3). Thus, we found a greater
number of effect estimates that were larger in the adolescent/
young adults compared with the older adults than expected by
chance alone (P ¼ 0.007). Further, we found no association
between BMI and rs7359397 (near SH2B1) in the adolescent/
young adult meta-analysis, even though we had greater than
80% power to detect an effect. Possibly, this locus contributes
more to BMI during a later time point in the lifespan. Although
the genome-wide comparison of the effect sizes for BMI in
middle-aged adults (GIANT) and the adolescent/young adult
sample did not identify any loci with genome-wide significant
differences, it is notable that 22 of the 23 SNPs that displayed
P-values of ,5 × 1025 had larger magnitude of effects in the
adolescents and young adults compared with the middle-aged
adults. Twenty-one of the 22 SNPs have not been previously
reported in the literature for BMI or obesity. Notably,
rs9391253 is highly correlated (r2. 0.8) with SNPs near
LIN28B (rs7759938, rs314268 and rs314276), which have
been associated with height and menarche. Another SNP,
rs9923856, is moderately (r2 ¼ 0.4) correlated with SNPs
near CLEC16A/KIAA0350 that have been associated with
type 1 diabetes.
The proportion of variance explained by the 7 loci showing
genome-wide significance in young adults and the 32 established
BMI loci was slightly (but not significantly) larger for ARIC
individuals in young adulthood than middle-aged adulthood.
The analysis of all common SNPs using GCTA suggested that
the total proportion of variance explained by common SNPs
for BMI was similar between young adulthood and middle-age;
however, differences in individual SNPs or rare variants may
still exist.
Studies in European pediatric populations have shown asso-
ciations of childhood obesity with TNNI3K and SEC16B (17).
TNNI3K is a novel cardiac troponin I-interacting kinase gene
(23), but its role in body weight and obesity is unclear. The
lack of association observed in the adolescent/young adult
period for SH2B1 is supported by the published literature.
Studies in European pediatric populations have also failed to
find an association between SH2B1 and BMI or obesity
(6,14,15). It is possible that SH2B1, a neuronal gene implicated
in glucose homeostasis and leptin signaling (24,25), fails to play
a measurable effect on BMI until other endogenous or exogenous
factors that only manifest or accumulate later in life occur.
Alternatively, perhaps it takes a long time for the cumulative
effects of the genetic variant to substantially alter BMI. Consist-
ent with a potential cumulative effect, studies in mice show that a
deficiency of SH2B1 results in metabolic disorders such as
obesity and diabetes; and when SH2B1 expression is restored,
it protects against obesity and diabetic phenotypes in a dose-
dependent manner (26).
Distinct genetic effects during adolescence/young adulthood
are also more broadly supported by the literature. A study in
European adolescents and children found that effect sizes for
BMI were more pronounced in children than in adults for
TMEM18, SEC16B and KCTD15, whereas a locus near BNDF
was comparatively smaller in children (27). In addition, a
study of variation in the association between FTO and MC4R
gene variants with body size over the life course from birth to
age 53 years showed that the association reached peak strength
at age 20 and then weakened during later adulthood (28). We
did not find any nominally significant differences in young
adult and adult effect estimates for these two loci. However,
the effect estimates for the MC4R locus (rs571312) was slightly
larger in young adults compared with adults [Supplementary
Material, Table S4, beta (SE) difference ¼ 0.022 (0.012), P ¼
0.07].MC4R are expressed in hypothalamic tissue, the metabolic
control center, which is outstandingly active during adolescence
and young adulthood (29–31). In a previous study, odds ratios
for eight loci (FTO, TMEM18, MC4R, TNNI3K, SEC16B,
GNDPA2, QPCTL and BNDF) nominally associated with
obesity in children (15) also appeared to be larger than those
reported for adult obesity in the GIANT study (4). Among the
possible biological mechanisms, larger effect sizes of loci on
BMI earlier in life may be due to alterations in factors that, for
example, regulate metabolism and glycemic homeostasis.
These factors may be more sensitive to genetic alterations
early in life, whereas at older ages, other environmental elements
may play a larger role. We can speculate that we observed larger
effect estimates during adolescence and young adulthood because
this group captures a relatively narrow age range marked by
post-pubertal growth and body composition changes. In contrast,
the adult sample spanned a large age range (aged 18–90), with a
comparatively stable period of weight change. It is possible that
the current generation of young adults having matured in a com-
paratively more obesogenic environment might have experienced
differential contribution of genetic influences on weight. It is
also possible that over time, and with age, the obesogenic
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environment plays a comparatively stronger role in body weight
than genetic factors.
We acknowledge that there are limitations in our study,
including the range of years in data collection between cohorts
across the meta-analysis sample. In addition, although we did
not observe substantial heterogeneity in effects across study
samples, it is possible that some gender differences may have
been overlooked by combining women and men. The year of
data collection was controlled for in family cohorts where data
collection spanned across generations. However, secular differ-
ences between cohorts still may influence our results. The use of
combined self-report and measured height could also be an issue,
as self-reported height and weight may be subject to under-
reporting bias (32,33), particularly in individuals with higher
BMI. Although our sample is the heretofore largest to span the
adolescent to young adult years, an even larger sample would
have permitted the detection of smaller BMI–SNP associations.
Despite the limitations, the current study strengthens the
current understanding of genetic influences on BMI during a
narrow period of the life cycle. Even with a limited sample
size, we detected associations with previously reported genetic
loci for BMI. Further, we provide evidence for an underlying
genetic predisposition to obesity that may have greater influence
on body weight during the period of adolescence compared with
adulthood. The current understanding of the epidemiological
architecture of these genetic effects across the life cycle, as
well as gene–gene and gene–environment effects in develop-
mental trajectories across lifespan remains incomplete with
many aspects still to be studied; however, our study does
provide additional insight into the role of genetic factors
during the critical time period from late adolescence and early
adulthood.
MATERIALS AND METHODS
Study design
We designed a two-stage study comprising a genome-wide
association meta-analysis (discovery sample) of data on up to
13 627 genotyped individuals from 10 studies and selected the
most promising SNPs after filtering (n ¼ 76) for follow-up ana-
lysis in up to 16 253 additional genotyped individuals from four
studies. Subjects were excluded if they were not of European
ethnicity, lacked information for BMI between 16 and 25 years
or had extreme values for BMI that were outside of +4 SD
from the cohort-specific mean. We removed potential outliers
for BMI (e.g. .4 SD) in order to ensure that BMI was normally
distributed for the analysis. All cohorts for discovery sample
included observations for BMI measured or reported between
ages 16 and 21 (n ¼ 13 627) and follow-up cohorts included
observations for BMI between the ages of 16 and 25 (n ¼ 16 253).
Study population and genotyping
Discovery sample of GWASs
The discovery meta-analysis samples came from10 GWASs,
including the British 1958 Birth Cohort (B58C), Framingham
Heart Study (FHS), GENEVA Dental Caries Study, Sardinian
Study on Aging (SardiNIA), Prostate, Lung, Colorectal, and
Ovarian Cancer Screening Trial (PLCO), Nurses’ Health
Study (NHS), Health Professionals Follow-up Study (HPFS),
Study of Health in Pomerania (SHIP), Estonian Genome
Center, University of Tartu (EGCUT), and Erasmus Rupchen
Family (ERF) (Supplementary Material, Tables S1–S3). The
sample size for these studies ranged from 65 to 4171 individuals,
with a combined sample size of 13 627. All studies were geno-
typed using Affymetrix or Illumina whole genome genotyping
arrays. To allow for meta-analysis across different marker sets,
imputation of the polymorphic SNPs from the HapMap2
European CEU population was performed using MACH (34)
or IMPUTE (35) or BimBam (36).
Follow-up sample of GWASs
The follow-up sample consisted of four additional GWAS: ARIC,
Fels Longitudinal Study (Fels) and additional participants from
the B58C and PLCO studies (i.e. PLCO2; Supplementary
Material, Tables S1–S3). Data were available for 16 253 indivi-
duals that were genotyped using Affymetrix or Illumina whole
genome genotyping arrays. For ARIC, B58C and PLCO, the poly-
morphic SNPs from the HapMap2 European CEU population
were imputed using MACH (34).
Statistical analyses
Association analyses with BMI
Each study performed single-marker association analyses with
BMI calculated from measured or self-reported height and
weight at adolescence or early adulthood, as the dependent
variable, using an additive genetic model implemented in
MACH2QTL (Y. Li et al., unpublished data), PLINK (37),
SNPTEST (35), ProbAbel (38), SOLAR (39), Merlin (40) or
linear-mixed effects models in R (lmekin) (41). Prior to analysis,
BMI was adjusted for age, study center and principal compo-
nents to correct for population substructure using linear regres-
sion. The adjusted BMI residuals were then transformed using
an inverse normal transformation with a mean of zero and
standard deviation of 1, which in turn was used as the phenotype
outcome for association analyses with each SNP. Analyses were
stratified by sex and by case status, when applicable. FHS,
SardiNIA, ERF and Fels used a linear mixed-effects model clus-
tering individuals in families so as to account for relatedness
between these individuals, using Merlin (38), lmekin in R (39)
or proc mixed in SAS with a random effect for family. For
each study, we excluded SNPs with poor imputation quality
scores (r2.hat , 0.3 in MACH or BimBam or proper info
,0.4 in SNPTEST) and a minor allele count (MAC ¼ 2N ×
minor allele frequency) ,20. Genomic control was applied to
each study which had lambda values ranging from 0.984 to
1.034. The results of the discovery meta-analysis were followed
by an additional overall genomic control correction in METAL.
Before the correction, the genomic control lambda for the
discovery results was 1.061. After correction, the genomic
control lambda was 0.999.
Meta-analysis
The meta-analyses for discovery and follow-up stages and the
combined discovery and follow-up stage used a fixed effects
approach by weighting the effect size estimates with the inverse
of the standard errors. We validated effect estimates from the
standard error weighted method with the sample size weighted
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z-score method, which is based on the direction of association and
P-values of each individual study. Both meta-analyses were per-
formed using METAL (http://www.sph.umich.edu/csg/abeca
sis/metal) and the correlation between the resulting 2log10
P-values was high (r. 0.99). All SNP association analyses
were tested for between sample heterogeneity.
To assess the validity of discovery findings, the most promis-
ing SNPs from the discovery meta-analysis were taken forward
into the four follow-up studies. After filtering based on r2, 0.1
and a distance of +500 kb using PLINK v1.07 (http://pngu.m
gh.harvard.edu/purcell/plink/), we identified 76 SNPs with
P, 5 × 1025 for follow-up. The results from the follow-up
studies were meta-analyzed as described above. We considered
SNPs that reached genome-wide significance at P , 5 × 1028
in the combined meta-analysis of the discovery and follow-up
studies to be noteworthy. Although we did not require the
SNPs to reach a particular significance level in the follow-up
analyses, it should be noted that all genome-wide significant
results from discovery and follow-up stages combined were at
least nominally significant in the meta-analysis of the follow-up
studies only.
In a sensitivity analyses in the combined discovery and
follow-up samples, we ran association analyses of BMI with
76 loci of interest separately on those with self-reported BMI
or with measured BMI (Supplementary Material, Table S4b).
Accounting for sample size differences, the effect sizes were
similar.
Conditional meta-analysis
We performed conditional analysis for three 1 Mb regions of
the genome where we identified significant associations for
SNPs (rs591120, near SEC16B; rs1561288, near POMC;
rs17066846, near MC4R) that had low linkage disequilibrium
(r2 ≤ 0.3) with the previously published SNPs in the GIANT
consortium (4). We tested the independence of the indicated
SNPs within the following 1 Mb regions: (i) chromosome
1, 175.8–176.8 Mb, which captures our SNP, rs591120, and
the GIANT SNP, rs543874 (SEC16B); (ii) chromosome 2,
24.8–25.8 Mb, which captures our SNP, rs1561288, and the
GIANT SNP, rs713586 (ADCY3, POMC, DTNB) and (iii)
chromosome 18, 55.5–56.6 Mb, which captures our most sig-
nificant SNP, rs7234864, and a possible secondary locus,
rs17066846, and the GIANT SNP, rs571312 (MC4R,
PMAIP1). These conditional analyses were conducted using
the following equation, where SNP1 and SNP2 are the two
SNPs of interest in the region:
transformed BMI residual = a+ b1SNP1 + b2SNP2 + error.
Comparison of effect sizes for known BMI loci
The 32 loci associated with BMI in Europeans identified from the
GIANT consortium (4) were meta-analyzed in the combined dis-
covery and follow-up studies as described above. We compared
our effect sizes from inverse normally transformed BMI with
effect sizes in middle-aged adults of European ancestry from
GIANT replication studies (4), also inverse normally trans-
formed. Nine of the 14 studies included in our analysis had over-
lapping samples with GIANT. Although the BMI measurements
utilized were different (i.e. adolescence/early adulthood versus
middle-aged adulthood), we accounted for the correlation due
to overlapping samples in our comparison. We used z-tests to
compare effect estimates (b) from our study (A) and the
GIANT study (B) adjusting for the correlation due to overlap-
ping samples such that:
bA − bBNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMe
(SEA)2 + (SEB)2 − 2(r)(SEA)(SEB)
√ ,
where SE is the standard error and r the Pearson correlation co-
efficient between the effect estimates. We calculated the Pearson
correlation coefficient between our study and GIANT using the
discovery stage data from both studies. The significance level
(P-value) was based on a two-tailed z-test.
In a sensitivity analyses, we compared effect sizes in each
young adults that did and did not contribute middle-aged BMI
observations to GIANT and with effect sizes in middle-aged
adults of European ancestry from GIANT replication studies
(Supplementary Material, Tables S5a and S5b). Accounting
for sample size differences, the differences in effect sizes
between young adults and middle-aged adults are similar regard-
less of their contribution to the GIANT analysis.
Genome-wide comparison of effect sizes
As a comprehensive comparison of age-related differences in
effects, we compared effect sizes adolescent/young adult
samples with effect sizes in middle-aged adults of European
ancestry from GIANT stage 1 cohorts (4) on a genome-wide
level. Estimates from inverse normally transformed BMI were
used in the z-test comparisons, as described above, to compare
the effect estimates across the genome. To assess the number
of loci from the z-test comparisons, all results were filtered
based on a linkage disequilibrium of r2, 0.1, a distance
of+500 kb and P, 5 × 1025 using PLINK v1.07 (http://
pngu.mgh.harvard.edu/purcell/plink/). SNPs were excluded if
the sample size for each the adolescent/young adult sample or
the GIANT sample fell below the mean.
Proportion of variance explained and GCTAs
Using two of the largest cohorts in our sample, British 1958 Birth
Cohort and the ARIC cohort, we estimated the proportion of
variance explained by the 7 loci that were genome-wide signifi-
cant in the combined meta-analyzed young adults and also for the
32 GIANT BMI-associated loci at late adolescence/early adult-
hood. These two cohorts also spanned the adolescent/young
adult age range; the British 1958 Birth Cohort participants had
BMI at 16 years and the ARIC cohort sample provided self-
reported heights and weights at 25 years of age. As a comparison,
we again estimated the proportion of variance explained by the 7
loci and the 32 GIANT BMI-associated loci for middle-aged
adults using BMI measurements at 45–64 years of age (mean
age 54.3 years) from the ARIC cohort. Untransformed BMI resi-
duals, adjusted for sex and age, were linearly regressed on each
set of SNPs (i.e. the genome-wide significant 7 loci or 32 GIANT
BMI-associated loci).
To explore the contribution of common SNPs to BMI, we esti-
mated the variance explained by all the autosomal SNPs for BMI
in early adulthood (25 years of age) and also middle-age (mean
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age 54.3 years) in ARIC, using the method proposed by Yang
et al. (40) and implemented in the GCTA software package
(http://www.complextraitgenomics.com/software/gcta/).
Power
We estimated the power to detect a genome-wide significant as-
sociation for our two-stage study assuming an additive genetic
model, a combined sample size of 29 880 young adults and an
alpha level of 5 × 1028. Based on effect sizes published in Euro-
pean populations, we had at least 80% power for to detect an
effect genome-wide for SNPs where the allele frequency was
at least 0.2 and the effect size was.0.25 kg/m2 (Supplementary
Material, Fig. S6). We also calculated power to detect associa-
tions in the 32 previously identified GIANT SNPs assuming an
additive genetic model, a sample size of 29 880 young adults
and a a level of 0.05. As shown in Table 3, we have .80%
power to detect over half (19 of 32) of the loci. Power estimates
were calculated using QUANTO v1.2.4 (http://hydra.usc.edu/
gxe/).
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Supplementary Material is available at HMG online.
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